Sofinnova Partners SAS insider trades: CinCor Pharma (CINC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sofinnova Partners SAS reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | CINC | ↑ Buy | 133,333 | $30.00 | $4.0M | By Sofinnova Capital IX | Aug 17, 2022 (2d) |
| Jan 11, 2022 | CINC | ↑ Buy | 220,000 | $16.00 | $3.5M | By Sofinnova Capital IX | Jan 13, 2022 (2d) |
| Apr 21, 2021 | HOOK | ↓ Sell | 328,620 | $11.60 | $3.8M | Direct | Apr 23, 2021 (2d) |
| Mar 29, 2021 | HOOK | ↓ Sell | 36,829 | $13.67 | $504K | Direct | Mar 31, 2021 (2d) |
| Mar 26, 2021 | HOOK | ↓ Sell | 35,171 | $13.69 | $482K | Direct | Mar 31, 2021 (5d) |
| Mar 25, 2021 | HOOK | ↓ Sell | 28,546 | $13.12 | $375K | Direct | Mar 29, 2021 (4d) |
| Mar 24, 2021 | HOOK | ↓ Sell | 52,690 | $13.70 | $722K | Direct | Mar 26, 2021 (2d) |
| Mar 23, 2021 | HOOK | ↓ Sell | 40,000 | $13.91 | $556K | Direct | Mar 25, 2021 (2d) |
| Mar 22, 2021 | HOOK | ↓ Sell | 40,534 | $14.54 | $589K | Direct | Mar 24, 2021 (2d) |
| Mar 19, 2021 | HOOK | ↓ Sell | 166,230 | $14.60 | $2.4M | Direct | Mar 23, 2021 (4d) |
| Oct 2, 2020 | HOOK | ↓ Sell | 300 | $10.00 | $3K | Direct | Oct 6, 2020 (4d) |
| Sep 15, 2020 | HOOK | ↓ Sell | 41,597 | $12.61 | $524K | Direct | Sep 17, 2020 (2d) |
| Jul 20, 2020 | HOOK | ↓ Sell | 12,483 | $11.94 | $149K | Direct | Jul 22, 2020 (2d) |
| Jun 29, 2020 | HOOK | ↓ Sell | 3,280 | $11.78 | $39K | Direct | Jul 22, 2020 (23d) |
| Jun 29, 2020 | HOOK | ↓ Sell | 3,280 | $11.78 | $39K | Direct | Jul 1, 2020 (2d) |
| Apr 23, 2019 | HOOK | ↑ Buy | 357,142 | $14.00 | $5.0M | Direct | Apr 25, 2019 (2d) |
| Oct 29, 2014 | FLXN | ↓ Sell | 10,000 | $20.00 | $200K | Direct | Jan 22, 2015 (85d) |
| Feb 18, 2014 | FLXN | ↑ Buy | 230,769 | $13.00 | $3.0M | Direct | Feb 20, 2014 (2d) |
| Apr 16, 2013 | OMTH | ↑ Buy | 625,000 | $8.00 | $5.0M | Direct | Apr 18, 2013 (2d) |
| Apr 16, 2013 | OMTH | ↓ Sell | 196 | $8.00 | $2K | Direct | Apr 18, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Sofinnova Partners SAS's insider trades
Sofinnova Partners SAS is a 10% owner of CinCor Pharma (CINC). Since Apr 16, 2013, it has reported 5 open-market purchases worth $20.5M and 15 sales worth $10.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (4 filings), shares returned to the company (1 filing), other transactions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CINC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.